Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

F-18 fluorodeoxyglucose uptake and water-perfusable tissue fraction in assessment of myocardial viability.

Iida H, Ruotsalainen U, Mäki M, Haaparnata M, Bergman J, Voipio-Pulkki LM, Nuutila P, Koshino K, Knuuti J.

Ann Nucl Med. 2012 Oct;26(8):644-55. doi: 10.1007/s12149-012-0631-2. Epub 2012 Jul 15.

2.

Free vs total pregnancy-associated plasma protein A (PAPP-A) as a predictor of 1-year outcome in patients presenting with non-ST-elevation acute coronary syndrome.

Lund J, Wittfooth S, Qin QP, Ilva T, Porela P, Pulkki K, Pettersson K, Voipio-Pulkki LM.

Clin Chem. 2010 Jul;56(7):1158-65. doi: 10.1373/clinchem.2009.136960. Epub 2010 May 6.

PMID:
20448189
3.

Heme oxygenase 1 polymorphisms and plasma concentrations in critically ill patients.

Saukkonen K, Lakkisto P, Kaunisto MA, Varpula M, Voipio-Pulkki LM, Varpula T, Pettilä V, Pulkki K.

Shock. 2010 Dec;34(6):558-64. doi: 10.1097/SHK.0b013e3181e14de9.

PMID:
20386498
4.

Heme oxygenase-1 and carbon monoxide promote neovascularization after myocardial infarction by modulating the expression of HIF-1alpha, SDF-1alpha and VEGF-B.

Lakkisto P, Kytö V, Forsten H, Siren JM, Segersvärd H, Voipio-Pulkki LM, Laine M, Pulkki K, Tikkanen I.

Eur J Pharmacol. 2010 Jun 10;635(1-3):156-64. doi: 10.1016/j.ejphar.2010.02.050. Epub 2010 Mar 19.

PMID:
20303947
5.

Reversal of atrial remodeling after cardioversion of persistent atrial fibrillation measured with magnetocardiography.

Lehto M, Jurkko R, Parikka H, Mäntynen V, Väänänen H, Montonen J, Voipio-Pulkki LM, Toivonen L, Laine M.

Pacing Clin Electrophysiol. 2009 Feb;32(2):217-23. doi: 10.1111/j.1540-8159.2008.02205.x.

PMID:
19170911
6.

Early markers of myocardial injury: cTnI is enough.

Ilva T, Lund J, Porela P, Mustonen H, Voipio-Pulkki LM, Eriksson S, Pettersson K, Tanner P, Pulkki K.

Clin Chim Acta. 2009 Feb;400(1-2):82-5. doi: 10.1016/j.cca.2008.10.005. Epub 2008 Nov 1.

PMID:
18992232
7.

The heme oxygenase inducer hemin protects against cardiac dysfunction and ventricular fibrillation in ischaemic/reperfused rat hearts: role of connexin 43.

Lakkisto P, Csonka C, Fodor G, Bencsik P, Voipio-Pulkki LM, Ferdinandy P, Pulkki K.

Scand J Clin Lab Invest. 2009;69(2):209-18. doi: 10.1080/00365510802474392.

PMID:
18946777
8.

The etiology and prognostic significance of cardiac troponin I elevation in unselected emergency department patients.

Ilva TJ, Eskola MJ, Nikus KC, Voipio-Pulkki LM, Lund J, Pulkki K, Mustonen H, Niemelä KO, Karhunen PJ, Porela P.

J Emerg Med. 2010 Jan;38(1):1-5. doi: 10.1016/j.jemermed.2007.09.060. Epub 2008 Aug 8.

PMID:
18687565
9.

Patient knowledge of atrial fibrillation: 3-month follow-up after an emergency room visit.

Koponen L, Rekola L, Ruotsalainen T, Lehto M, Leino-Kilpi H, Voipio-Pulkki LM.

J Adv Nurs. 2008 Jan;61(1):51-61. doi: 10.1111/j.1365-2648.2007.04465.x.

PMID:
18173735
10.

Detection of proximal coronary occlusion in acute coronary syndrome: a feasibility study using computerized electrocardiographic analysis.

Eskola MJ, Nikus KC, Voipio-Pulkki LM, Huhtala H, Lund J, Ilva T, Niemelä KO, Porela P.

Ann Noninvasive Electrocardiol. 2007 Oct;12(4):301-5.

11.

Universal definition of myocardial infarction.

Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernández-Avilés F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar N.

Circulation. 2007 Nov 27;116(22):2634-53. Epub 2007 Oct 19. No abstract available.

PMID:
17951284
12.

Duodecimin hiljainen enemmistö.

Kaila M, Mäkelä M, Helin-Salmivaara A, Hiltunen L, Hyöty M, Ketola E, Laru-Sompa R, Mukala K, Niinistö L, Patja K, Salmenpohja H, Tulamo R, Voipio-Pulkki LM.

Duodecim. 2007;123(11):1249-50. Finnish. No abstract available.

PMID:
17763642
13.

Association of cell-free plasma DNA with hospital mortality and organ dysfunction in intensive care unit patients.

Saukkonen K, Lakkisto P, Varpula M, Varpula T, Voipio-Pulkki LM, Pettilä V, Pulkki K.

Intensive Care Med. 2007 Sep;33(9):1624-7. Epub 2007 May 31.

PMID:
17541553
14.

Incidence of fatal myocarditis: a population-based study in Finland.

Kytö V, Saraste A, Voipio-Pulkki LM, Saukko P.

Am J Epidemiol. 2007 Mar 1;165(5):570-4. Epub 2007 Jan 19.

PMID:
17237135
15.

The effect of emergency department delay on outcome in critically ill medical patients: evaluation using hospital mortality and quality of life at 6 months.

Saukkonen KA, Varpula M, Räsänen P, Roine RP, Voipio-Pulkki LM, Pettilä V.

J Intern Med. 2006 Dec;260(6):586-91.

16.

Quality of emergency room care for atrial fibrillation.

Kyhälä-Valtonen H, Lehto M, Rossinen J, Pajari R, Mustonen H, Koponen L, Kohvakka A, Lehtonen L, Toivonen L, Voipio-Pulkki LM.

Scand Cardiovasc J. 2006 Oct;40(5):267-73.

PMID:
17012136
17.

Cardiomyocyte apoptosis is related to left ventricular dysfunction and remodelling in dilated cardiomyopathy, but is not affected by growth hormone treatment.

Ibe W, Saraste A, Lindemann S, Bruder S, Buerke M, Darius H, Pulkki K, Voipio-Pulkki LM.

Eur J Heart Fail. 2007 Feb;9(2):160-7. Epub 2006 Aug 4.

18.

Nivelreuman Käypä hoito -suosituksen toimeenpanokoulutus 2001-2002.

Anttolainen M, Peltomaa R, Voipio-Pulkki LM, Pekka Turunen J.

Duodecim. 2006;122(9):1069-78. Finnish. No abstract available.

PMID:
16866338
19.

Pregnancy-associated plasma protein A: a biomarker in acute ST-elevation myocardial infarction (STEMI).

Lund J, Qin QP, Ilva T, Nikus K, Eskola M, Porela P, Kokkala S, Pulkki K, Pettersson K, Voipio-Pulkki LM.

Ann Med. 2006;38(3):221-8.

PMID:
16720436
20.

Comparative accuracy of manual versus computerized electrocardiographic measurement of J-, ST- and T-wave deviations in patients with acute coronary syndrome.

Eskola MJ, Nikus KC, Voipio-Pulkki LM, Huhtala H, Parviainen T, Lund J, Ilva T, Porela P.

Am J Cardiol. 2005 Dec 1;96(11):1584-8. Epub 2005 Oct 14.

PMID:
16310446
21.

Measurement and reproducibility of magnetocardiographic filtered atrial signal in patients with paroxysmal lone atrial fibrillation and in healthy subjects.

Koskinen R, Lehto M, Väänänen H, Rantonen J, Voipio-Pulkki LM, Mäkijärvi M, Lehtonen L, Montonen J, Toivonen L.

J Electrocardiol. 2005 Oct;38(4):330-6. Epub 2005 Jun 23.

PMID:
16216607
22.

Diagnosis and presentation of fatal myocarditis.

Kytö V, Saukko P, Lignitz E, Schwesinger G, Henn V, Saraste A, Voipio-Pulkki LM.

Hum Pathol. 2005 Sep;36(9):1003-7.

PMID:
16153464
23.

Hemodynamic variables related to outcome in septic shock.

Varpula M, Tallgren M, Saukkonen K, Voipio-Pulkki LM, Pettilä V.

Intensive Care Med. 2005 Aug;31(8):1066-71. Epub 2005 Jun 23.

PMID:
15973520
24.

Thalidomide therapy and polyneuropathy in myeloma patients.

Laaksonen S, Remes K, Koskela K, Voipio-Pulkki LM, Falck B.

Electromyogr Clin Neurophysiol. 2005 Mar;45(2):75-86.

PMID:
15861857
25.

Comparison of cardiac troponin I immunoassays variably affected by circulating autoantibodies.

Eriksson S, Ilva T, Becker C, Lund J, Porela P, Pulkki K, Voipio-Pulkki LM, Pettersson K.

Clin Chem. 2005 May;51(5):848-55. Epub 2005 Feb 17.

PMID:
15718488
26.

Cytomegalovirus infection of the heart is common in patients with fatal myocarditis.

Kytö V, Vuorinen T, Saukko P, Lautenschlager I, Lignitz E, Saraste A, Voipio-Pulkki LM.

Clin Infect Dis. 2005 Mar 1;40(5):683-8. Epub 2005 Feb 4.

PMID:
15714413
27.

Improved early risk stratification and diagnosis of myocardial infarction, using a novel troponin I assay concept.

Ilva T, Eriksson S, Lund J, Porela P, Mustonen H, Pettersson K, Pulkki K, Voipio-Pulkki LM.

Eur J Clin Invest. 2005 Feb;35(2):112-6.

PMID:
15667582
28.

Molecular distinction of circulating pregnancy-associated plasma protein A in myocardial infarction and pregnancy.

Qin QP, Kokkala S, Lund J, Tamm N, Voipio-Pulkki LM, Pettersson K.

Clin Chem. 2005 Jan;51(1):75-83.

PMID:
15613709
29.

Apoptotic cardiomyocyte death in fatal myocarditis.

Kytö V, Saraste A, Saukko P, Henn V, Pulkki K, Vuorinen T, Voipio-Pulkki LM.

Am J Cardiol. 2004 Sep 15;94(6):746-50. Erratum in: Am J Cardiol. 2005 Feb 1;95(3):438.

PMID:
15374778
30.

[There is no graduation from life-long medical schools].

Voipio-Pulkki LM, Turunen JP.

Duodecim. 2004;120(11):1307-8. Finnish. No abstract available.

PMID:
15327082
31.

Increased pulse pressure is associated with reduced baroreflex sensitivity.

Virtanen R, Jula A, Huikuri H, Kuusela T, Helenius H, Ylitalo A, Voipio-Pulkki LM, Kauma H, Kesäniemi YA, Airaksinen J.

J Hum Hypertens. 2004 Apr;18(4):247-52.

PMID:
15037873
32.

Out-of-hospital hypoglycaemia is safely and cost-effectively treated by paramedics.

Mattila EM, Kuisma MJ, Sund KP, Voipio-Pulkki LM.

Eur J Emerg Med. 2004 Apr;11(2):70-4.

PMID:
15028894
33.

Glutathione depletion and cardiomyocyte apoptosis in viral myocarditis.

Kytö V, Lapatto R, Lakkisto P, Saraste A, Voipio-Pulkki LM, Vuorinen T, Pulkki K.

Eur J Clin Invest. 2004 Mar;34(3):167-75.

PMID:
15025674
34.

Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes.

Bäcklund T, Palojoki E, Saraste A, Eriksson A, Finckenberg P, Kytö V, Lakkisto P, Mervaala E, Voipio-Pulkki LM, Laine M, Tikkanen I.

Diabetologia. 2004 Feb;47(2):325-30. Epub 2004 Jan 13.

PMID:
14722653
35.

Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation.

Lund J, Qin QP, Ilva T, Pettersson K, Voipio-Pulkki LM, Porela P, Pulkki K.

Circulation. 2003 Oct 21;108(16):1924-6. Epub 2003 Oct 6.

PMID:
14530192
36.

Anxiety and hostility are associated with reduced baroreflex sensitivity and increased beat-to-beat blood pressure variability.

Virtanen R, Jula A, Salminen JK, Voipio-Pulkki LM, Helenius H, Kuusela T, Airaksinen J.

Psychosom Med. 2003 Sep-Oct;65(5):751-6.

PMID:
14508016
37.

Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis.

Saraste A, Arola A, Vuorinen T, Kytö V, Kallajoki M, Pulkki K, Voipio-Pulkki LM, Hyypiä T.

Cardiovasc Pathol. 2003 Sep-Oct;12(5):255-62.

PMID:
14507574
38.

Reduced heart rate variability in hypertension: associations with lifestyle factors and plasma renin activity.

Virtanen R, Jula A, Kuusela T, Helenius H, Voipio-Pulkki LM.

J Hum Hypertens. 2003 Mar;17(3):171-9.

PMID:
12624607
39.

Effect of vasopeptidase inhibitor omapatrilat on cardiomyocyte apoptosis and ventricular remodeling in rat myocardial infarction.

Bäcklund T, Palojoki E, Saraste A, Grönholm T, Eriksson A, Lakkisto P, Vuolteenaho O, Nieminen MS, Voipio-Pulkki LM, Laine M, Tikkanen I.

Cardiovasc Res. 2003 Mar;57(3):727-37.

PMID:
12618234
40.

Expression of heme oxygenase-1 in response to myocardial infarction in rats.

Lakkisto P, Palojoki E, Bäcklund T, Saraste A, Tikkanen I, Voipio-Pulkki LM, Pulkki K.

J Mol Cell Cardiol. 2002 Oct;34(10):1357-65.

PMID:
12392996
41.

Neurophysiologic parameters and symptoms in chronic renal failure.

Laaksonen S, Metsärinne K, Voipio-Pulkki LM, Falck B.

Muscle Nerve. 2002 Jun;25(6):884-90.

PMID:
12115978
42.

Exercise training in chronic heart failure: beneficial effects on cardiac (11)C-hydroxyephedrine PET, autonomic nervous control, and ventricular repolarization.

Pietilä M, Malminiemi K, Vesalainen R, Jartti T, Teräs M, Någren K, Lehikoinen P, Voipio-Pulkki LM.

J Nucl Med. 2002 Jun;43(6):773-9.

43.

Soluble tumor necrosis factor receptor levels identify a subgroup of heart failure patients with increased cardiomyocyte apoptosis.

Saraste A, Voipio-Pulkki LM, Heikkilä P, Laine P, Nieminen MS, Pulkki K.

Clin Chim Acta. 2002 Jun;320(1-2):65-7.

PMID:
11983202
44.

Adenosine in myocardial protection given through three windows of opportunity. An experimental study with pigs.

Vähäsilta T, Virtanen J, Saraste A, Luotolahti M, Pulkki K, Valtonen M, Voipio-Pulkki LM, Savunen T.

Scand Cardiovasc J. 2001 Dec;35(6):409-14.

PMID:
11837521
45.

Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats.

Palojoki E, Saraste A, Eriksson A, Pulkki K, Kallajoki M, Voipio-Pulkki LM, Tikkanen I.

Am J Physiol Heart Circ Physiol. 2001 Jun;280(6):H2726-31.

46.

Reduced myocardial carbon-11 hydroxyephedrine retention is associated with poor prognosis in chronic heart failure.

Pietilä M, Malminiemi K, Ukkonen H, Saraste M, Någren K, Lehikoinen P, Voipio-Pulkki LM.

Eur J Nucl Med. 2001 Mar;28(3):373-6.

PMID:
11315607
47.

Use of [11C]acetate and [15O]O2 PET for the assessment of myocardial oxygen utilization in patients with chronic myocardial infarction.

Ukkonen H, Knuuti J, Katoh C, Iida H, Sipilä H, Lehikoinen P, Någren K, Voipio-Pulkki LM.

Eur J Nucl Med. 2001 Mar;28(3):334-9.

PMID:
11315601
48.

Apoptosis.

Borgers M, Voipio-Pulkki L, Izumo S.

Cardiovasc Res. 2000 Feb;45(3):525-527. No abstract available.

PMID:
11274981
49.

Feasibility of, and success in adopting a low-fat diet in coronary patients.

Hämäläinen H, Paalosmaa-Puusa P, Seppänen R, Rastas M, Knuts LR, Voipio-Pulkki LM.

Scand J Rehabil Med. 2000 Dec;32(4):180-6.

PMID:
11201625
50.

The Sensitivity of Exercise Echocardiography Can Be Improved by Taking the Delayed Myocardial Contraction into Account.

Luotolahti M, Saraste M, Voipio-Pulkki LM, Hartiala J.

Echocardiography. 1998 May;15(4):345-352.

PMID:
11175047

Supplemental Content

Loading ...
Support Center